Hormonal Contraceptive Market Scope And Analysis

  • Report Code : TIPRE00004959
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Hormonal Contraceptive Market Trends and Scope by 2031

Buy Now

Hormonal Contraceptive Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 4%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Method
  • Combined Oral Contraceptives
  • Oral Contraceptives
  • Implanted Contraceptives
  • Injected Contraceptives
  • Intrauterine
  • Transdermal Patch
  • Vaginal Ring
By Hormones
  • Androgens
  • Estrogens
  • Progestogens
  • Gonadotropins
  • Antiandrogens
  • Others
By End User
  • Hospitals
  • Homecare
  • Gynecology Centers
  • Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Amgen
  • Bayer Healthcare Pharmaceuticals
  • Cipla Limited
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals Inc
  • Novartis AG
  • Pfizer Inc
  • Piramal Healthcare Limited
  • Sun Pharmaceutical Industries Ltd